Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Fierce Pharma
Sarepta extends $700M debt to 2030 amid Elevidys uncertainty
The debt refinancing and private placement represent Sarepta's latest move in a series of intensive measures to improve its financial position.
Angus Liu
Aug 21, 2025 10:52am
Kite sails into in vivo CAR-T space via $350M Interius buyout
Aug 21, 2025 9:59am
Dynavax's vaccine holds its own against Shingrix in early test
Aug 21, 2025 8:00am
After 'complete standstill,' biotech market reaches new normal
Aug 20, 2025 11:04am
FDA draft recommends all cancer trials collect OS data
Aug 20, 2025 10:59am
Painted into a corner, Mural agrees to Xoma buyout
Aug 20, 2025 10:28am
